- Home
- SPE vs SCPH Comparison
SPE vs SCPH Comparison
Compare SPE & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPE
- SCPH
- Stock Information
- Founded
- SPE 1993
- SCPH 2013
- Country
- SPE United States
- SCPH United States
- Employees
- SPE N/A
- SCPH N/A
- Industry
- SPE Finance/Investors Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- SPE Finance
- SCPH Health Care
- Exchange
- SPE Nasdaq
- SCPH Nasdaq
- Market Cap
- SPE 147.3M
- SCPH 173.6M
- IPO Year
- SPE N/A
- SCPH 2017
- Fundamental
- Price
- SPE $14.83
- SCPH $2.47
- Analyst Decision
- SPE
- SCPH Strong Buy
- Analyst Count
- SPE 0
- SCPH 3
- Target Price
- SPE N/A
- SCPH $14.00
- AVG Volume (30 Days)
- SPE 25.4K
- SCPH 251.8K
- Earning Date
- SPE 01-01-0001
- SCPH 05-16-2025
- Dividend Yield
- SPE 8.55%
- SCPH N/A
- EPS Growth
- SPE N/A
- SCPH N/A
- EPS
- SPE N/A
- SCPH N/A
- Revenue
- SPE N/A
- SCPH $36,332,000.00
- Revenue This Year
- SPE N/A
- SCPH $109.32
- Revenue Next Year
- SPE N/A
- SCPH $76.95
- P/E Ratio
- SPE N/A
- SCPH N/A
- Revenue Growth
- SPE N/A
- SCPH 167.28
- 52 Week Low
- SPE $10.26
- SCPH $1.94
- 52 Week High
- SPE $12.59
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- SPE 57.81
- SCPH 50.24
- Support Level
- SPE $14.75
- SCPH $2.24
- Resistance Level
- SPE $14.94
- SCPH $2.64
- Average True Range (ATR)
- SPE 0.22
- SCPH 0.17
- MACD
- SPE 0.08
- SCPH 0.02
- Stochastic Oscillator
- SPE 91.67
- SCPH 59.62
About SPE Special Opportunities Fund Inc
Special Opportunities Fund Inc is a closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.